ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
19.069,53
0,36%
S&P 500
5.910,52
-0,11%
Dow Jones
43.396,55
-0,03%
Euro vs US Dollar
1,05271
-0,18%
Bitcoin
96.907,84
2,70%
Pepperstone
Advertisement
Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE
  6. Poolbeg Pharma Plc (POLB)

  7. Poolbeg Pharma Plc (POLB) News

POLB

Poolbeg Pharma (POLB)

Poolbeg Pharma Plc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:LSE:POLB
DatumZeitQuelleÜberschriftSymbolFirma
20/11/202419h26Alliance NewsAlliance NewsPoolbeg Pharma granted US patent for influenza treatmentLSE:POLBPoolbeg Pharma Plc
20/11/202419h26Alliance NewsAlliance NewsPoolbeg Pharma granted US patent for influenza treatmentLSE:POLBPoolbeg Pharma Plc
20/11/202408h00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 Patent Granted in United StatesLSE:POLBPoolbeg Pharma Plc
06/11/202408h00RNS Non-RegulatoryPoolbeg Pharma PLC POLB 001 data to be presented at ASHLSE:POLBPoolbeg Pharma Plc
18/09/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Interim results for the six months to 30 June 2024LSE:POLBPoolbeg Pharma Plc
27/08/202408h00RNS Non-RegulatoryPoolbeg Pharma PLC H.C. Wainwright Global Investment ConferenceLSE:POLBPoolbeg Pharma Plc
12/08/202414h28RNS Regulatory NewsPoolbeg Pharma PLC Holding(s) in CompanyLSE:POLBPoolbeg Pharma Plc
26/07/202419h59Alliance NewsAlliance NewsEARNINGS AND TRADING: Man Group profit rises; Petershill AUM increasesLSE:POLBPoolbeg Pharma Plc
26/07/202419h59Alliance NewsAlliance NewsEARNINGS AND TRADING: Man Group profit rises; Petershill AUM increasesLSE:POLBPoolbeg Pharma Plc
26/07/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Voluntary Delisting from OTCQB MarketLSE:POLBPoolbeg Pharma Plc
10/07/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Notification of Major HoldingsLSE:POLBPoolbeg Pharma Plc
02/07/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Change of Registered AddressLSE:POLBPoolbeg Pharma Plc
17/06/202409h38RNS Regulatory NewsPoolbeg Pharma PLC Result of AGMLSE:POLBPoolbeg Pharma Plc
09/05/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Annual Report & AGM NoticeLSE:POLBPoolbeg Pharma Plc
01/05/202417h39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202417h39Alliance NewsAlliance NewsPoolbeg Pharma celebrates full patent approval for Immunomodulator IILSE:POLBPoolbeg Pharma Plc
01/05/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Significant POLB 001 Patent Granted in USALSE:POLBPoolbeg Pharma Plc
30/04/202417h30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202417h30Alliance NewsAlliance NewsEARNINGS: Avacta sales jump; Poolbeg loss narrows; Digital 9 NAV downLSE:POLBPoolbeg Pharma Plc
30/04/202408h02RNS Regulatory NewsPoolbeg Pharma PLC Appointment of Joint BrokerLSE:POLBPoolbeg Pharma Plc
30/04/202408h01RNS Regulatory NewsPoolbeg Pharma PLC Option Agreement to Acquire Orphan Drug CandidateLSE:POLBPoolbeg Pharma Plc
30/04/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Results for the year ended 31 December 2023LSE:POLBPoolbeg Pharma Plc
29/04/202408h00RNS Regulatory NewsPoolbeg Pharma PLC TR-1: Notification of major holdingsLSE:POLBPoolbeg Pharma Plc
20/03/202417h18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202417h18Alliance NewsAlliance NewsEARNINGS AND TRADING: Roadside Real Estate trims Cambridge Sleep stakeLSE:POLBPoolbeg Pharma Plc
20/03/202408h00RNS Regulatory NewsPoolbeg Pharma PLC POLB 001 US Patent UpdateLSE:POLBPoolbeg Pharma Plc
22/02/202408h00RNS Regulatory NewsPoolbeg Pharma PLC Director/PDMR ShareholdingLSE:POLBPoolbeg Pharma Plc
19/02/202414h42RNS Regulatory NewsPoolbeg Pharma PLC Director Share PurchaseLSE:POLBPoolbeg Pharma Plc
15/02/202417h02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
15/02/202417h02Alliance NewsAlliance NewsTRADING UPDATES: Diversified Energy offers dividend alternativeLSE:POLBPoolbeg Pharma Plc
 Showing the most relevant articles for your search:LSE:POLB

Kürzlich von Ihnen besucht

AMEX
BTCO
Invesco Galaxy Bitcoin ETF
ASX
SGP
Stockland
LSE
EHG
Elegant Hotels
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten